0 items USD 0.00Search
Your search for "mrrpb5 global commercial portion control scales market research report 2019" gave back 979 results.
Vijaya Bank - Strategy, SWOT and Corporate Finance Report Summary Vijaya Bank - Strategy, SWOT and Corporate Finance Report, is a source of...
Catalog:
MarketLine
March 2019
Price: USD 175.00
CESC Limited - Strategy, SWOT and Corporate Finance Report Summary CESC Limited - Strategy, SWOT and Corporate Finance Report, is a source of...
Catalog:
MarketLine
January 2023
Price: USD 175.00
Waste Management in India Summary Waste Management in India industry profile provides top-line qualitative and quantitative summary information...
Catalog:
MarketLine
June 2020
Price: USD 350.00
Residential Construction in India Summary Residential Construction in India industry profile provides top-line qualitative and quantitative summary...
Catalog:
MarketLine
September 2020
Price: USD 350.00
Ramky Infrastructure Limited - Strategy, SWOT and Corporate Finance Report Summary Ramky Infrastructure Limited - Strategy, SWOT and Corporate...
MarketLine
January 2023
Price: USD 175.00
Omaxe Ltd - Strategy, SWOT and Corporate Finance Report Summary Omaxe Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive...
MarketLine
January 2023
Price: USD 175.00
Ircon International Limited - Strategy, SWOT and Corporate Finance Report Summary Ircon International Limited - Strategy, SWOT and Corporate Finance...
MarketLine
October 2019
Price: USD 175.00
Gujarat Sidhee Cement Ltd - Strategy, SWOT and Corporate Finance Report Summary Gujarat Sidhee Cement Ltd - Strategy, SWOT and Corporate Finance...
MarketLine
January 2023
Price: USD 175.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. From being an enzyme venture, Biocon successfully emerged as a...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Lupin mainly comprise of APIs and...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Ipca Labs was founded by K.B. Mehla and Dr. N.S. Tibrawala in 1949...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Divis labs are Active Pharma Ingredients,...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The key business segments of Aurobindo Pharma are APIs, Formulations...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
Canara Bank - Strategy, SWOT and Corporate Finance Report Summary Canara Bank - Strategy, SWOT and Corporate Finance Report, is a source of...
Catalog:
MarketLine
January 2023
Price: USD 175.00
GAIL (India) Limited - Strategy, SWOT and Corporate Finance Report Summary GAIL (India) Limited - Strategy, SWOT and Corporate Finance Report, is a...
Catalog:
MarketLine
January 2023
Price: USD 175.00
